C.R. Bard Inc is recalling 4,698 Bard and BD InLay Optima Ureteral Stent Kits because the actual size of the stent inside the package may not match the size listed on the label. This labeling discrepancy means healthcare providers could unknowingly attempt to use an incorrectly sized stent during a medical procedure. The affected products were distributed to hospitals and medical facilities worldwide between November 2025 and the present.
Using a stent of the wrong size can result in surgical delays while a replacement is found or improper drainage of the kidney. In some cases, it could lead to physical injury during insertion or removal if the physician is unaware that the device size differs from the expected dimensions.
Recall #: Z-0905-2026; Quantity: 116 units
Recall #: Z-0906-2026; Quantity: 4350 units
Recall #: Z-0907-2026; Quantity: 116 units
Recall #: Z-0908-2026; Quantity: 116 units
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.